Go Back

Company or ticker...

Penumbra

Penumbra develops innovative medical therapies for vascular and neurological conditions.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

PEN

12.7B

8.4

79

2.36%

Key Facts

M. Cap

PS

PE

YTD

12.7B

8.4

79

2.36%

10MA

20MA

50MA

200MA

$PEN

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now